Noradrenalina Kalceks (Norepinephrine)

Norepinephrine, the active ingredient in Noradrenalina Kalceks, is an adrenergic agonist presented as an injectable solution for intravenous use. It is employed to raise blood pressure in acute hypotension, manage various forms of shock, and support circulation during cardiac arrest in critical care settings.

GNH USA supplies Noradrenalina Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global healthcare providers.

Norepinephrine acts on the adrenergic system to restore vascular tone in critical care conditions.

Hypotension: increases systemic vascular resistance to raise blood pressure in patients with acute low blood pressure. Shock: restores perfusion by constricting blood vessels, improving organ blood flow during distributive or septic shock. Cardiac arrest: provides vasoconstrictive support to maintain coronary and cerebral perfusion during resuscitation efforts.

Norepinephrine may be associated with a range of adverse reactions, varying from frequent to rare but serious.

Common Side Effects: - Headache: pressure sensation due to rapid blood pressure rise. - Tachycardia: increased heart rate from β1 stimulation. - Arrhythmia: irregular heart rhythms, especially in susceptible patients. - Peripheral ischemia: reduced blood flow to extremities causing discomfort.

Serious or Rare Side Effects: - Severe hypertension: excessive blood pressure elevation risking vascular injury. - Myocardial ischemia: reduced coronary perfusion leading to chest pain or infarction. - Tissue necrosis at infusion site: extravasation causing local tissue damage. - Pulmonary edema: fluid accumulation in lungs due to increased afterload.

When using norepinephrine, careful monitoring and specific precautions are essential to ensure patient safety. - Monitor blood pressure: continuous arterial pressure monitoring is required to titrate infusion. - Assess cardiac function: evaluate heart performance and ischemic risk before and during therapy. - Adjust dose cautiously in coronary artery disease: avoid excessive vasoconstriction that may worsen myocardial oxygen demand. - Avoid extravasation: administer through a central venous catheter whenever possible. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norepinephrine can interact with several medications, influencing its efficacy or safety profile.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis due to amplified catecholamine effects. - Tricyclic antidepressants: additive pressor response may cause severe hypertension. - Beta‑blockers: may blunt the desired increase in heart rate and cardiac output.

Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin): may reduce norepinephrine’s pressor effect, requiring dose adjustments. - ACE inhibitors: can enhance hypotensive episodes when norepinephrine is tapered. - Calcium channel blockers: may affect vascular tone and necessitate close blood pressure monitoring.